Bibliographic citations
Hoyos, J., (2016). Uso de oxitocina durante el trabajo de parto como factor de riesgo para hiperbilirrubinemia neonatal en el hospital IV Víctor Lazarte Echegaray [Tesis, Universidad Privada Antenor Orrego]. https://hdl.handle.net/20.500.12759/1558
Hoyos, J., Uso de oxitocina durante el trabajo de parto como factor de riesgo para hiperbilirrubinemia neonatal en el hospital IV Víctor Lazarte Echegaray [Tesis]. PE: Universidad Privada Antenor Orrego; 2016. https://hdl.handle.net/20.500.12759/1558
@misc{renati/1346408,
title = "Uso de oxitocina durante el trabajo de parto como factor de riesgo para hiperbilirrubinemia neonatal en el hospital IV Víctor Lazarte Echegaray",
author = "Hoyos Castro, Jhon Alexander",
publisher = "Universidad Privada Antenor Orrego",
year = "2016"
}
The neonatal hyperbilirrubinemia is one of the pathologies of mayor incidence between the services of neonatology, due to that reason it’s of great importance the determination of the risk factors associated to it. OBJETIVE: To determine if there is an association between the uso of oxytocin during the labor and neonatal hyperbilirrubinemia. MATERIAL AND METHODS: it’s an retrospective, analytic, cases and control study, with a population study conformed by 126 patients (42 cases and 84 controls); the group of cases was conformed by neonate with neonatal hyperbilirrubinemia that acomplished the criteria for inclusion and exclusion, while the control group was conformed by 84 healthy neonates; we searched through clinic records in which oxytocine was used in labor and then we proceed to register the data and analyse it. Results: The proportion of neonates with neonatal hyperbilirrubinemia in whose mothers was used oxytocine was 93% and the proportion of healhy neonates whose mother weren’t exposed to oxytocine was 75%. When comparing the results, the value of p was 0,016( p< 0,05); with IC 95% of 1,212 to 15,491. Conclusions: its detemined the use of oxytocine during labor is a risk factor to the development of neonatal hyperbilirrubinemia
This item is licensed under a Creative Commons License